Equities research analysts expect Bed Bath & Beyond Inc. (NASDAQ:BBBY) to post sales of $1.86 billion for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Bed Bath & Beyond’s earnings, with the lowest sales estimate coming in at $1.84 billion and the highest estimate coming in at $1.90 billion. Bed Bath & Beyond posted sales of $1.31 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 42%. The business is expected to report its next quarterly earnings report on Wednesday, July 14th.
According to Zacks, analysts expect that Bed Bath & Beyond will report full year sales of $8.14 billion for the current year, with estimates ranging from $8.05 billion to $8.20 billion. For the next fiscal year, analysts expect that the company will report sales of $8.13 billion, with estimates ranging from $7.89 billion to $8.26 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that that provide coverage for Bed Bath & Beyond.
Bed Bath & Beyond (NASDAQ:BBBY) last posted its quarterly earnings results on Wednesday, April 14th. The retailer reported $0.40 EPS for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.09. Bed Bath & Beyond had a negative return on equity of 8.44% and a negative net margin of 1.63%. The company had revenue of $2.62 billion for the quarter, compared to analysts’ expectations of $2.65 billion. During the same period in the previous year, the firm earned $0.38 EPS. The firm’s revenue was down 15.7% compared to the same quarter last year.
In other Bed Bath & Beyond news, CFO Gustavo Arnal purchased 20,000 shares of the firm’s stock in a transaction on Friday, April 16th. The stock was bought at an average cost of $25.45 per share, for a total transaction of $509,000.00. Following the completion of the purchase, the chief financial officer now owns 300,769 shares in the company, valued at approximately $7,654,571.05. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Joshua Schechter purchased 3,000 shares of the firm’s stock in a transaction on Friday, April 16th. The stock was acquired at an average price of $25.02 per share, with a total value of $75,060.00. Following the completion of the purchase, the director now owns 24,016 shares of the company’s stock, valued at approximately $600,880.32. The disclosure for this purchase can be found here. Insiders have purchased a total of 23,500 shares of company stock valued at $596,835 over the last 90 days. 1.00% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the business. Vantage Consulting Group Inc purchased a new stake in Bed Bath & Beyond in the fourth quarter valued at about $25,000. Logan Capital Management Inc. purchased a new stake in Bed Bath & Beyond in the first quarter valued at about $29,000. Ameritas Investment Company LLC purchased a new stake in Bed Bath & Beyond in the first quarter valued at about $34,000. Signaturefd LLC purchased a new stake in Bed Bath & Beyond in the fourth quarter valued at about $43,000. Finally, WASHINGTON TRUST Co purchased a new stake in Bed Bath & Beyond in the first quarter valued at about $44,000. Institutional investors own 95.57% of the company’s stock.
NASDAQ BBBY traded down $2.75 during trading hours on Friday, reaching $31.54. The company’s stock had a trading volume of 223,777 shares, compared to its average volume of 10,786,169. The stock has a market cap of $3.36 billion, a P/E ratio of -26.62 and a beta of 1.83. Bed Bath & Beyond has a 1 year low of $7.30 and a 1 year high of $53.90. The business’s 50-day moving average is $27.23. The company has a quick ratio of 0.85, a current ratio of 1.58 and a debt-to-equity ratio of 0.93.
Bed Bath & Beyond Company Profile
Bed Bath & Beyond Inc, together with its subsidiaries, operates a chain of retail stores. It operates through two segments, North American Retail and Institutional Sales. The company sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.